无保护左主干冠状动脉闭塞所致急性心肌梗死直接经皮冠状动脉介入治疗的最优策略(OPTIMAL):随机对照试验研究方案
OPTIMAL研究是一项开放标签、随机、多中心临床试验,计划在中国大陆30家医院纳入480例无保护左主干冠状动脉闭塞所致急性心肌梗死患者,按1:1随机分配至立即支架植入组或延迟支架植入组(直接血管成形术后4-10天预定支架植入)。主要终点为随机化后30天全因死亡或再发心肌梗死的复合终点,旨在比较延迟支架植入与立即支架植入的临床效果。
要点
- 针对左主干闭塞所致急性心肌梗死,直接PCI死亡率及主要不良心血管事件风险较高。
- 延迟支架植入可能通过减少远端栓塞和无复流现象改善直接PCI预后。
- OPTIMAL研究为开放标签、随机、多中心临床试验,计划纳入480例患者,1:1随机分组。
核心结论
- OPTIMAL研究旨在比较延迟支架植入与立即支架植入在左主干冠状动脉闭塞所致急性心肌梗死中的临床效果。
研究设计与样本
- 开放标签、随机、多中心临床试验,计划从中国大陆30家医院纳入480例无保护左主干冠状动脉闭塞所致急性心肌梗死患者,按1:1随机分配至立即支架植入组或延迟支架植入组(直接血管成形术后4-10天预定支架植入)。
关键数值与推荐
- 主要终点为随机化后30天全因死亡或再发心肌梗死的复合终点。
- 次要结局包括30天、6个月和12个月的全因死亡、心源性死亡、再发心肌梗死和非计划靶血管血运重建。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary percutaneous coronary intervention (PCI) for patients presenting with acute myocardial infarction (AMI) caused by left main coronary artery occlusion is associated with significantly higher mortality and risks of major adverse cardiovascular events. Deferred stent implantation may improve prognosis of primary PCI by reducing distal embolization and no-reflow phenomenon. There is no randomized clinical trial focusing on the effect and outcome of deferred stent implantation on primary PCI for left main coronary artery occlusion in contrast with conventional strategy. METHODS: The Optimal Strategy of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction due to Unprotected Left Main Coronary Artery Occlusion (OPTIMAL) study (ClinicalTrials.gov Identifier: NCT03282773) is an open-label, randomized, multicenter clinical trial in which 480 patients presenting with AMI caused by left main coronary artery occlusion recruited from 30 hospitals in mainland China will be randomly assigned 1:1 to immediate stenting or deferred stenting (scheduled 4-10 days after primary angioplasty) groups. The primary endpoint is a composite of all-cause mortality or recurrent myocardial infarction at 30 days after randomization. The secondary outcomes include all-cause mortality, cardiac death, recurrent myocardial infarction, and unplanned target vessel revascularization at 30 days, 6 months, and 12 months. DISCUSSION: The OPTIMAL study is designed to compare the clinical performance of deferred stenting with that of immediate stenting for AMI caused by left main coronary artery occlusion. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03282773 . Registered on 10 September 2017.
引用
- Gao Y, Zhang F, Li C, et al. Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion (OPTIMAL): study protocol for a randomised controlled trial. Trials. 2019. PMID: 30850023. doi:10.1186/s13063-019-3211-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。